Format

Send to

Choose Destination
Int J Surg. 2009 Aug;7(4):347-9. doi: 10.1016/j.ijsu.2009.05.001. Epub 2009 May 14.

5-years of endovenous laser ablation (EVLA) for the treatment of varicose veins--a prospective study.

Author information

1
Department of Vascular and Endovascular Surgery, Bart's and the London NHS Trust, The Royal London Hospital, London, UK.

Abstract

PURPOSE:

This prospective study evaluates the results of Endovenous laser ablation (EVLA) for the treatment of varicose veins.

METHODS:

Data were prospectively collected for all patients undergoing EVLA for varicose veins in our unit including clinical outcomes (CEAP classification) and post-operative duplex.

RESULTS:

624 EVLA procedures were performed from April 2004 to February 2009. There were 527 LSV EVLA cases, 449 of which were for the above-knee segment only. There were 94 SSV EVLA cases and 3 patients needed LSV EVLA on the same leg at the same time. 84% were done under general anesthetic including 126 patients who underwent bilateral procedures at the same session. There were no intra-operative complications, and a 1% incidence of thrombophlebitis, and <1% incidence of neuropraxia. During a median follow-up of 20 months (Range 2-51) there was no clinical or duplex evidence of recurrence and no recannalisation of the treated vein.

CONCLUSIONS:

Our 5-year experience suggests that EVLA is a safe and effective alternative to conventional surgery for the treatment of varicose veins. Bilateral procedures were well tolerated by patients even under local anaesthesia.

PMID:
19446660
DOI:
10.1016/j.ijsu.2009.05.001
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center